Combinational Mushroom and Cannabis Bio-Pharmaceuticals, Created using AI.
Targeting the underserved $2.16 Trillion medical markets of cancer, mental health, inflammation, obesity, and viral infection treatment, as well as preventative care and wellness with strategic IP and AI trade secrets.
Explore the science of AionOur Objective
Aion challenges Big Pharma’s ineffective focus on reactive treatments and drugs with a successful bio-pharmaceutical method using plant-based medicines with psychoactive &/or non-psychoactive properties; all driven by Artificial Intelligence.
Big Pharma uses expensive, synthetic drugs that are harmful to everyone. These prescription drugs are the 4th leading cause of death and are responsible for 45% of overdoses more than cocaine, heroin, and amphetamines combined.
We Aim At Treating The 5 Largest Disease Categories...
Cancer
Over 18 Million cancer diagnoses annually.
$100 Billion annually.
Mental Health
450 Million people suffer from mental health disorders.
$60 Billion annually.
Inflammation
Over 300 Million chronic inflammation sufferers.
$93.88 Billion annually.
And General Wellness...
Disease Prevention
Prevention of diseases with immune-boosting properties.
Anxiety
Reduction of anxiety and calming of the nervous system.
Hormones
Aids with hormonal imbalances.
Of the top 150 prescription drugs, at least 118 are based on natural sources:
74% come from plants
Paclitaxel (Pacific yew tree)
18% come from fungi
Cyclosporin (Tolypocladium inflatum)
Why AION Plant Based Bio-Pharmaceuticals?
The Global Botanical and plant-derivative drug market is anticipated to grow from $26 Billion in 2017 to $53 Billion by 2026. This boom in the market is being driven by a growing number of applications in multiple disease categories, new FDA approvals, advances in technology and manufacturing, and rising demand for naturally sourced medicines.
up to 90% failure rate with current cancer treatments
60-70% of current depression treatments are unsuccessful
Current synthetic drugs carry significant health risks
Big Pharma costs trillions of dollars & millions of lives
https://www.inkwoodresearch.com/reports/botanical-and-plant-derivative-drug-market/
Our Patents
Aion’s 28 proprietary formulations & patented treatments combine distillate from medical cannabis and medical mushrooms to create natural optimized combinatorial formulations, nothing synthetic.
Currently, Aion has filed 5 patents combining mushroom and cannabis compounds that target:
- Cancer
- Mental Health
- Inflammation
- Viral Infections
- Obesity
Aion has created 28 formulations utilizing cannabis and mushroom extracts including:
- Psilocybin only formulations
- Mushroom only formulations
- Medicinal Cannabis only formulations
- Mushroom + Medicinal Cannabis (CBD or THC)
- Mushroom + Whole Plant Cannabis (CBD or THC)
